MLPA® Kits

For a description how to create and adapt MLPA Kits, that are not available on this page, please have a look at our User Manual MLPA.

Import of SALSA MLPA® kit descriptions via the SEQUENCE Pilot operation "Mixes [master file] / button [Import]".

Mix
Version
Date
Region
Application
Vs. 01
17-08-2011
Chromosome Y Y-Chromosome Microdeletions
Vs. 06
23-07-2013
Chromosome Y Y-Chromosome Microdeletions
Vs. 07
09-11-2015
Chromosome Y Y-Chromosome Microdeletions
Vs. 08
29-07-2016
Chromosome Y Y-Chromosome Microdeletions
Vs. 01
20-07-2011
USH2A 1q41 Usher syndrome
Vs. 02
15-02-2012
USH2A 1q41 Usher syndrome
Vs. 03
21-12-2012
USH2A 1q41 Usher syndrome
Vs. 04
13-08-2015
USH2A 1q41 Usher syndrome
Vs. 05
06-04-2016
USH2A 1q41 Usher syndrome
Vs. 01
20-07-2011
USH2A 1q41 Usher syndrome
P362-A1 Vs. 02 15-02-2012 USH2A 1q41 Usher syndrome
P362-A1
Vs. 03
21-12-2012
USH2A 1q41 Usher syndrome
P362-A1
Vs. 04
13-08-2015
USH2A 1q41 Usher syndrome
P362-A2
Vs. 05
06-04-2016
USH2A 1q41 Usher syndrome
Vs. 01
04-03-2010
7p, 15q-cen, 16p, 21q-cen, 21q Subtelomere screening
Vs. 07
03-12-2014
7p, 15q-cen, 16p, 21q-cen, 21q Subtelomere screening
Vs. 01
01-06-2010
CHM-RP2-RPGR Retinitis pigmentosa (RP)
Vs. 04
23-07-2014
CHM-RP2-RPGR Retinitis pigmentosa (RP)
Vs. 05
02-02-2015
CHM-RP2-RPGR Retinitis pigmentosa (RP)
Vs. 06
23-10-2015
CHM-RP2-RPGR Retinitis pigmentosa (RP)
Vs. 02
01-07-2010
BEST1 (=VDM2), PRPH2 (=RDS) Macular Dystrophy, Vitelliform
Vs. 06
21-06-2013
BEST1 (=VDM2), PRPH2 (=RDS) Macular Dystrophy, Vitelliform
Vs. 07
13-08-2015
BEST1 (=VDM2), PRPH2 (=RDS) Macular Dystrophy, Vitelliform
Vs. 08
02-06-2017
BEST1 (=VDM2), PRPH2 (=RDS) Macular Dystrophy, Vitelliform
Vs. 03
06-09-2011
10p13; DCLRE1C SCID and Omenn syndrome
Vs. 01
23-01-2012
17p11.2 Smith-Magenis syndrome
Vs. 02
21-12-2012
17p11.2 Smith-Magenis syndrome
Vs. 04
21-08-2015
17p11.2 Smith-Magenis syndrome
Vs. 03
02-12-2012
BRAF, IDH1, IDH2 Gliomas
P370-A1 Vs. 04 24-12-2011 BRAF, IDH1, IDH2 Gliomas
P370-B1 Vs. 06 16-09-2014 BRAF, IDH1, IDH2 Gliomas
Vs. 01
25-12-2008
2p16, Langer Giedion, 9q22, WAGR, 15q24, 17q21 Microdeletion follow-up
Vs. 07
10-04-2014
2p16, Langer Giedion, 9q22, WAGR, 15q24, 17q21 Microdeletion follow-up
P372-A1 Vs. 05 09-03-2012 Sotos, DiGeorge, Rubinstein-Taybi, NF1 Microdeletion follow-up
P372-B1 Vs. 07 13-11-2013 Sotos, DiGeorge, Rubinstein-Taybi, NF1 Microdeletion follow-up
Vs. 03
18-08-2009
1p36, 3q29, Wolf-Hirschlorn, Cri du Chat, Phelan-McDermid Microdeletion follow-up
Vs. 09
13-11-2013
1p36, 3q29, Wolf-Hirschlorn, Cri du Chat, Phelan-McDermid Microdeletion follow-up
Vs. 02
02-07-2009
7q11, PWS/AS, Miller-Dieker, Smith-Magenis, RETT Microdeletion follow-up
Vs. 06
24-02-2014
7q11, PWS/AS, Miller-Dieker, Smith-Magenis, RETT Microdeletion follow-up
Vs. 07
30-01-2017
7q11, PWS/AS, Miller-Dieker, Smith-Magenis, RETT Microdeletion follow-up
P376-B2 Vs. 04 01-03-2013 BRCA1ness BRCA1-mutated and sporadic tumours with BRCA1-like genomic profile
Vs. 02
20-10-2010
1p34 Colon cancer, stomach cancer (hereditary)
Vs. 04
30-08-2011
1p34 Colon cancer, stomach cancer (hereditary)
Vs. 05
24-01-2012
1p34 Colon cancer, stomach cancer (hereditary)
Vs. 06
02-12-2012
1p34 Colon cancer, stomach cancer (hereditary)
Vs. 09
02-10-2013
1p34 Colon cancer, stomach cancer (hereditary)
Vs. 10
13-06-2014
1p34 Colon cancer, stomach cancer (hereditary)
Vs. 12
15-01-2015
1p34 Colon cancer, stomach cancer (hereditary)
Vs. D1-01
23-02-2018
1p34 Colon cancer, stomach cancer (hereditary)
P379-A1 Vs. 02 14-01-2012 NRXN1 Pitt-Hopkins-like syndrome 2
P379-A1 Vs. 03 21-12-2012 NRXN1 Pitt-Hopkins-like syndrome 2
P379-A2 Vs. 04 12-05-2015 NRXN1 Pitt-Hopkins-like syndrome 2